Serum levels of IFN-γ, IL-2, IL-4, IL-5 and IL-10 in the course of specific immunotherapy of patients with atopic dermatitis

International Review of Allergology and Clinical Immunology

Volumn 7, Issue 1, 2001, Pages 27-33

  Czarnecka Operacz, M ^a   Silny, W ^a   Sobieska, M ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Atopic dermatitis; Serum cytokine level; Specific immunotherapy

Indexed keywords

GAMMA INTERFERON; HELISEN DEPOT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; VACCINE;

ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOTHERAPY; SCORING SYSTEM;

EID: 0035081509     PISSN: 12329142     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Allergen immunotherapy effective in asthma? A meta-analysis of randomised control trials
2. Epitope specific T-cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL2 and IL-15 in vitro
3. Role of interleukin 10 in specific immunotherapy
4. Venom immunotherapy modulated interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes
5. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels
6. Specific immunotherapy for allergic rhinitis in children
7. The leukotriene antagonist Zafirlukast as a therapeutic agent for atopic dermatitis
8. Specific hyposensitization in atopic dermatitis
9. Mediator release is altered in immunotherapy-treated patients: A 4 year study
10. Immunological mechanisms operative in allergen specific immunotherapy
11. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
12. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: Effect of immunotherapy
13. Atopic dermatitis
14. Mechanisms of specific immunotherapy
15. Cytokines in atopic dermatitis
16. Production of interferon and lymphoproliferative responses in whole blood cultures derived from patients with atopic dermatitis
17. Detection of circulating immune complexs in patients with atopic dermatitis and psoriasis
18. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels
19. Elevated levels of interteukin-2 receptor in sera of patients with atopic dermatitis and psoriasis
20. Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis
21. Involvement of complement in psoriasis and atopic dermatitis. - Measurement of C3a and C5a, C3, C4 and C1 inactivator
22. A method for the quantification of interleukin-4 in serum (sandwich ELISA) and IL-4 levels in patients with atopic dermatitis
23. Hyposensitization with alum precipitated extracts in atopic dermatitis: A placebo controlled study
24. Theory and practice of specific desensitization therapy of allergic skin disorders
25. Immunoregulatory abnormalities in atopic dermatitis
26. A novel therapy for atopic dermatitis with allergen-antibody complexes: A double-blind placebo-controlled study
27. The effect of immunotherapy on the cutaneous late phase response to antigen
28. Allergen specific immunotherapy for allegic rhinitis: A new insight into its clinical efficacy and mechanism
29. The effect of immunotherapy on bronchical hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients
30. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season
31. Systemic interferon gamma treatment in severe atopic dermatitis
32. Successful hyposesitization treatment in atopic eczema: Results of a trial in monozygotic twins
33. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis: A randomized, double-blind, placebo-controlled trial
34. T-cell function in atopic dermatitis - Controlled examination of concanavalin A-dose-response relations in cultured lymphocytes
35. Punktowy wskaźnik oceny stanu klinicznego chorych na atopowe zapalenie skóry
36. Double blind, controlled, crossover study of cyctosporin in adults with severe refractory atopic dermatitis
37. Production of IL-4, IL-2, IFN-a by peripheral blood mononuclear cells of patients with atopic dermatitis
38. Interleukin-1 release from peripheral blood monocytes and soluble interleukin-2 and CD8 receptors in serum from patients with atopic dermatitis
39. Suppression of late asthmatic reaction by hyposensitization in children allergic to house dust mite (Dermatophagoides pteronyssinus)
40. Non specific and specific hyposensitization in severe atopic dermatitis
41. Quantitive analysis of T-lymphocyte subsets in atopic eczema, using monoclonal antibodies and flow cytometry